Tag: Sleep Medicine
-

Apnimed Reports Positive Phase 2 Results for Sulthiame in Obstructive Sleep Apnea Published in The Lancet
Groundbreaking Phase 2 Results for Sulthiame in Obstructive Sleep Apnea Apnimed has announced that its Phase 2 FLOW study evaluating sulthiame, an oral carbonic anhydrase inhibitor, met the primary endpoint across all dosing regimens and demonstrated statistically significant improvements across multiple efficacy measures for obstructive sleep apnea (OSA). The positive findings were published in The…
-

Apnimed Publishes Positive Phase 2 Flow Study Results for Sulthiame in Obstructive Sleep Apnea in The Lancet
Overview: Promising Phase 2 Results in The Lancet Apnimed has announced that positive Phase 2 results from the FLOW study evaluating sulthiame, an oral carbonic anhydrase inhibitor, have been published in The Lancet. The publication highlights that sulthiame met the primary endpoint across all tested doses and significantly improved a range of efficacy measures in…
-

Apnimed Announces Lancet Publication: Positive Phase 2 Results for Sulthiame in Obstructive Sleep Apnea
New Lancet Publication Highlights Positive Phase 2 Outcomes Apnimed has revealed breakthrough findings from its Phase 2 FLOW study, showing that sulthiame, an oral carbonic anhydrase inhibitor, met the primary endpoint across all doses tested in obstructive sleep apnea (OSA). The Lancet publication details how sulthiame not only achieved statistical significance on primary measures but…
-

New AASM Guideline Updates Central Sleep Apnea Treatments, Emphasizing Individualized Care
Overview of the New AASM Guideline A task force from the American Academy of Sleep Medicine (AASM) has released updated clinical practice recommendations for the treatment of central sleep apnea (CSA). Published online as an accepted paper in the Journal of Clinical Sleep Medicine, the guideline replaces and expands upon the AASM’s earlier parameters from…
-

New US Study Links Chronic Insomnia to Faster Cognitive Decline and Dementia Risk
Chronic insomnia and brain aging: what the study found A large U.S. study from the Mayo Clinic has found that chronic insomnia in adults over 50 is linked to faster declines in memory and thinking, along with a higher risk of developing dementia. The research followed thousands of participants over several years, using detailed cognitive…
